Skip to main content
The Clinical Respiratory Journal logoLink to The Clinical Respiratory Journal
. 2022 Nov 15;17(1):29–39. doi: 10.1111/crj.13558

Characteristics and difference of respiratory diseases in Korean adults aged ≥40 years: A cross‐sectional study

Yoon Jae Won 1, Sook‐Hyun Lee 2, Yu‐Cheol Lim 2, Yoon Jae Lee 2, Maurits Van den Noort 3, Beom‐Joon Lee 4,5,, In‐Hyuk Ha 2,
PMCID: PMC9829619  PMID: 36380724

Abstract

Purpose

National big data pertaining to the status of common respiratory diseases is essential to devising appropriate policies to promote proper treatment and prevention of respiratory diseases amid the prolonged coronavirus disease 2019 (COVID‐19) pandemic. The aim of this study is to investigate the prevalence of common respiratory diseases and their association with sociodemographic characteristics, comorbidities, and medical history using 11 years (2008–2018) of the Korea National Health and Nutrition Examination Survey (KNHANES) data, ultimately to present foundational data for policy decision making and disease prevention measures.

Methods

Among the participants of the KNHANES survey (2008–2018), 93 028 adults aged ≥40 years who underwent a lung function test were included in this cross‐sectional study. The participants were divided into four groups: Asthma, chronic obstructive pulmonary disease (COPD), asthma + COPD, and no respiratory disease. Their data were analyzed for demographic factors, health behavior, and disease‐related factors. Multiple logistic regression was used to calculate the odds ratio (OR) adjusted for sex, age, household income, educational level, occupation, body mass index (BMI), smoking status, alcohol consumption, physical activity, and comorbidities.

Results

Of all participants, 1.83%, 12.63%, and 1.27% had only asthma, only COPD, and asthma + COPD, respectively. With respect to the patients with asthma who also had asthma + COPD, the OR of asthma + COPD was 5.272 in underweight patients and 6.479 in patients aged ≥70 years. Meanwhile, a high association between COPD and asthma + COPD was found in female patients, whereas asthma was more highly associated with asthma + COPD in male patients.

Conclusion

The study confirmed that old age, sex, smoking status, BMI, previous history of atopic dermatitis, and lung cancer were independent risk factors for asthma, COPD, and asthma + COPD. The present study demonstrated the need for a multidisciplinary integrative approach to respiratory diseases, and the findings could be used for developing policies for the treatment of COVID‐19 and respiratory diseases and the prevention of infectious diseases.

Keywords: asthma, COPD, KNHANES, Korean National Health and Nutrition Examination Survey


The odds ratio (OR) of having asthma + COPD among patients with asthma was lower in females and older people. Regarding BMI, risk of asthma + COPD was higher in underweight patients with asthma as compared with those with normal BMI, whereas the association was lower in overweight subjects. In contrast to asthma patients, females, older ages, and overweight patients with COPD had higher risk of asthma + COPD.

graphic file with name CRJ-17-29-g001.jpg

1. INTRODUCTION

The prevalence of respiratory diseases is gradually increasing due to worsening air pollution in recent years and the aging of society. Global Burden of Disease Study 2020 reported that deaths associated with lower respiratory tract infections have decreased over the past 20 years, and yet many deaths are still caused by respiratory diseases. 1 , 2

Asthma is a heterogeneous chronic inflammatory disease with several etiologies, and its symptoms include breathing difficulty and coughing. 3 In 2015, asthma was suspected to be one of the most common chronic respiratory diseases, affecting 358 million people worldwide. The prevalence rate of asthma has been reported to range between 0.7% and 11.9% in Asian countries, including South Korea. 4

Chronic obstructive pulmonary disease (COPD) is a lung disease characterized by irreversible airflow limitation that has become a public health issue with a high prevalence and mortality rate. According to the World Health Organization (WHO), COPD will become the third leading cause of death by 2030. The socio‐economic burden associated with COPD is substantial in Korea. The direct medical cost per COPD patient was $2800 in 2009, which was slightly higher than that of Canada and the United States. 5 COPD has a direct correlation with smoking status, but in some countries, air pollution, occupational exposure, and indoor air pollution due to the use of biomass are also key causes. 6

The definition of asthma + COPD remains controversial, with no commonly accepted definition. In clinical practice, diagnosis of asthma or COPD is suggested if three or more of the symptoms corresponding to asthma or COPD are present. On the other hand, diagnosis of asthma + COPD should be considered when the patient presents symptoms of asthma and COPD alike. 7 In general, asthma + COPD is diagnosed when asthma features are accompanied by irreversible airflow limitation. 8 asthma + COPD progresses faster and is associated with poorer health‐related quality of life, higher frequency of exacerbation, comorbidities, and health care utilization rate than asthma or COPD alone. The high economic burden of asthma + COPD, as compared with asthma and COPD, is well documented. 9 However, recommendations for managing asthma + COPD are ambiguous and are inferred from guidelines for asthma or COPD alone. 10

Previous studies have used the Korean National Health and Nutrition Examination Survey (KNHANES) data to investigate respiratory diseases. A study used data from the 2007–2012 KNHANES to divide patients with asthma + COPD into asthma‐dominant and COPD‐dominant groups to investigate their socio‐economic status and quality of life. The results showed that the asthma‐dominant asthma + COPD group had lower socio‐economic status and poorer quality of life than the COPD‐dominant asthma + COPD group. 11 Another study used data from the 2007–2011 KNHANES to assess the risk factors for COPD among Korean nonsmokers. The results showed that older age, male sex, low body mass index (BMI), asthma, and tuberculosis were risk factors for COPD among nonsmokers. 12

The COVID‐19 pandemic remains active since the index case in late 2019. COVID‐19 is known to have a greater repercussion on individuals with preexisting respiratory conditions, such as asthma and COPD. 13 This study investigated the status of respiratory diseases in South Korea until 2018, before the advent of COVID‐19. This data can be used in subsequent studies to comparatively analyze the status of respiratory diseases prior to and after the advent of COVID‐19.

As described, typical respiratory diseases include asthma, COPD, and asthma + COPD, but each disease has various risk factors according to its own characteristics. Previous studies have focused on the associations of a single factor, but no study has investigated that specific factor, among the multitude of complex factors, which shows the strongest association. Moreover, while previous studies have investigated asthma, COPD, and asthma + COPD separately, and some have investigated two of these diseases, no study has compared all three diseases during the period between 2008 and 2018. Accordingly, the present study aims to analyze the risk factors that influence asthma, COPD, and asthma + COPD and compare the risk factors using data from Korean adults aged ≥40 years from the KNHANES 2008–2018.

2. METHODS

2.1. Study design

KNHANES is a nationwide survey conducted by the Korea Centers for Disease Control and Prevention (KCDC), and the present study used data from the fourth to seventh KNHANES survey (KNHANES IV‐VII). Starting from 1998, KNHANES has been conducted in 3‐year waves. It is a nationwide health and nutrition survey with representativeness and reliability that has been conducted annually since 2007. The survey collects information on the general characteristics, health behavior, chronic disease status, and nutritional intake status of the Korean population. The findings are used as basic data for establishing health care policies.

2.2. Study participants

The present study used data from the KNHANES IV‐VII, collected between January 2008 and December 2018. In the present study, 93 028 individuals were surveyed, of which 35 235 adults aged ≥40 years who took part in a lung function test were included in the final analysis. Of the 93 028 surveyed individuals, 42 619 individuals aged <40 years and 15 174 individuals with missing data regarding asthma and COPD were excluded. Consequently, the analysis of the present study included a total of 35 235 individuals (Figure 1).

FIGURE 1.

FIGURE 1

Flow diagram showing the number of participants who were excluded and the number of data that were analyzed. COPD, chronic obstructive pulmonary disease

2.3. Study tools

2.3.1. General characteristics

Among the health questionnaire survey items in the KNHANES IV‐VII, the present study analyzed sex, age, household income, educational level, occupation, BMI, smoking status, alcohol consumption, physical activity, previous history, lung function test, and the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria.

Sex, age, household income, educational level, and occupation were selected as demographic characteristics. Age was divided into 40–49, 50–59, 60–69, and ≥70 years, whereas the educational level was divided into elementary school graduate or lower, middle school graduate, high school graduate, and college graduate or higher for individuals aged ≥40 years. For household income, the household equivalent income quartiles from the KNHANES (“low,” “middle‐low,” “middle‐high,” and “high”) were used. The occupation was divided into unemployed; professional; office work; sales and services; agriculture, forestry, and fishery; machine fitting and simple labor; and others.

BMI, smoking status, alcohol consumption, physical activity, previous history, lung function test, and GOLD criteria were analyzed as health‐related characteristics. BMI was divided into underweight (BMI < 18.5), normal (18.5 ≤ BMI < 25), and overweight (25 ≥ BMI) based on anthropometric results to calculate body weight (kg)/height2 (m2), in accordance with the WHO standards. 12 Smoking status was divided into current smoker, former smoker, and nonsmoker, whereas alcohol consumption was divided into none, ≤1, 2–3, and ≥4 drinks based on the monthly frequency of consumption. Physical activity was divided based on the frequency of walking during 1 week, with “No” for not walking at all and “Yes” for just once or two to seven times. Excluding asthma and COPD, we identified individuals who indicated a previous diagnosis of atopic dermatitis and lung cancer, which are typically associated with lung disease. Lung function test results were divided into four parameters: Predicted percentage of forced vital capacity [FVC (% pred)], predicted percentage of forced expiratory volume [FEV1 (% pred)], FEV1/FVC, and FEV1/FVC < 0.7. The four stages of the GOLD criteria were used as follows: stage 1 (mild) = FEV ≥ 80%; stage 2 (moderate) = 50% ≤ FEV < 80%; stage 3 (severe) = 30% ≤ FEV < 50%; and stage 4 (very severe) = FEV < 30%. 14

2.3.2. Definition of asthma group

The asthma group was defined as patients answering “Yes” to whether they had been diagnosed with asthma by a doctor.

2.3.3. Definition of COPD group

The COPD group was defined based on the results of the lung function test. FVC (% pred; mean ± SE) and FEV1 (% pred; mean ± SE) were determined and used to calculate FEV1/FVC (mean ± SE). Patients with FEV1/FVC < 0.7 were defined as having COPD. 15 , 16

2.3.4. Definition of asthma + COPD group

Individuals with both asthma and COPD were defined as the asthma + COPD group. Hence, this group was comprised of those who responded “Yes” to the question of whether they had been diagnosed with asthma by a doctor and who had an FEV1/FVC < 0.7. 17

2.4. Statistical analysis

KNHANES is a nationwide sample survey that used complex sample analysis considering weights, stratification variables, and cluster variables. The distribution of the characteristics of the study participants was expressed as frequency and percentage, while continuous data were expressed as mean and 95% confidence interval (95% CI). To identify the risk factors for asthma + COPD among patients with respiratory diseases, we performed logistic regression analysis with asthma + COPD as a binary dependent variable. Additionally, the risk factors for each respiratory disease were also analyzed using each respiratory disease (Asthma, COPD, asthma + COPD) as the dependent variable. Sex, age, household income, education, occupation, BMI, smoking status, alcohol consumption, physical activity, and type of comorbidity were included as covariates in the logistic regression analysis. Furthermore, the annual status of asthma, COPD, and asthma + COPD from 2008 to 2018 was investigated. The logistic regression results were presented as odds ratio (OR) and 95% CI. The data used in the present study were statistically analyzed using SAS V9.4 (SAS Institute Inc, Cary, NC, USA) with the significance level set to <0.05 (two‐tailed).

3. RESULTS

Among all Korean adults aged ≥40 years who underwent a lung function test, 1.83%, 12.63%, and 1.27% had asthma, COPD, and asthma + COPD, respectively. In the asthma group, the prevalence was three times higher in women than in men, whereas the prevalence among men was 3.2 and 1.2 times higher than that in women in the COPD and asthma + COPD groups, respectively. Table 1 shows the basic characteristics of the participants. Among the demographic characteristics, the age brackets with the highest number of participants were 40–49 years (31.28%), 60–69 years (32.58%), and ≥70 years (34.86%) in the asthma, COPD, and asthma + COPD groups, respectively. Regarding household income, asthma showed the highest prevalence in the high‐income group (26.15%), whereas COPD and asthma + COPD showed the highest prevalence in the low‐income group (29.25% and 39.48%, respectively). Whereas the most common education level was high school in the NRD group (35.77%), that in each of the three respiratory disease groups was elementary school (Asthma: 36.81%, COPD: 37.45%, asthma + COPD: 49.99%). In all groups, unemployed individuals accounted for the greatest percentage, and most patients had normal weight. While many individuals in the NRD and asthma group were nonsmokers, the percentage of smokers was relatively high in the COPD groups. Similarly, many individuals in the NRD, asthma, and asthma + COPD groups were nondrinkers (NRD: 26.88%, asthma: 41.74%, asthma + COPD: 40.9%), whereas the COPD group showed a higher proportion of current drinkers (36.15%). Concerning physical activity, all the four groups showed a higher proportion of subjects who regularly participated in physical activity (NRD: 82.69%, asthma: 82.54%, COPD: 79.43%, asthma + COPD: 78.86%).

TABLE 1.

Characteristics of Korean participants with asthma, COPD, and asthma + COPD in the KNHANES 2008–2018

Variables NRD (n = 29 690) Asthma only (n = 645) COPD only (n = 4452) Asthma + COPD (n = 448)
n % n % n % n %
Sex a Men 11 701 46.25 129 24.87 3300 76.43 241 55.61
Women 17 989 53.75 516 75.13 1152 23.57 207 44.39
Age (y) a , b 53.78 (53.60–53.95) 56.58 (55.53–57.63) 62.85 (62.46–63.24) 63.46 (62.08–64.83)
40–49 9567 40.28 141 31.28 310 11.65 42 14.32
50–59 9297 33.98 167 30.12 840 26.22 69 21.12
60–69 6856 16.91 185 21.82 1584 32.58 143 29.69
≥70 3970 8.83 152 16.78 1718 29.56 194 34.86
Household income a 1st quartile 5590 15.22 199 25.36 1502 29.25 191 39.48
2nd quartile 7401 24.68 146 22.25 1226 26.90 108 22.95
3rd quartile 7786 27.98 145 26.23 878 22.52 81 19.80
4th quartile 8913 32.12 155 26.15 846 21.33 68 17.76
Education a Elementary (<6 years) 8186 21.36 299 36.81 1876 37.45 235 49.99
Middle (7–9 years) 4318 14.01 92 16.53 754 17.40 64 13.28
High (10–12 years) 9654 35.77 141 24.00 1136 28.02 89 20.62
College (>12 years) 7532 28.86 113 22.65 686 17.13 60 16.12
Occupation a Unemployed 14 390 46.59 379 54.73 2507 54.94 291 63.73
Professions 607 2.51 7 1.18 82 2.02 3 0.77
Office work 2670 10.62 49 10.08 182 4.99 19 4.44
Sales and services 2201 8.65 25 5.16 165 4.73 11 3.21
Agriculture, forestry and fishery 2020 7.25 31 5.95 143 4.13 19 4.42
Machine fitting and simple labor 4691 14.27 94 13.76 838 17.01 60 12.01
Others 3111 10.10 60 9.14 535 12.18 45 11.41
BMI (kg/m2) a , b 24.32 (24.28–24.37) 25.02 (24.59–25.46) 23.71 (23.61–23.81) 23.91 (23.55–24.26)
Underweight 490 1.59 8 0.98 124 2.59 24 4.96
Normal weight 18 002 60.08 342 55.06 3012 66.89 271 59.67
Overweight 11 198 38.33 295 43.96 1316 30.52 153 35.37
Smoking status a Nonsmoker 18 779 57.33 488 72.01 1381 29.13 199 44.30
Former 4850 18.55 66 12.05 1422 31.81 116 25.09
Current 6061 24.12 91 15.94 1649 39.06 133 30.61
Alcohol consumption a None 9211 26.88 297 41.74 1442 29.29 199 40.90
≤1 drink/mo 8460 27.61 188 28.32 858 19.15 93 19.77
2 drinks/mo to 3 drinks/mo 9821 37.13 137 25.61 1488 36.15 110 27.77
≥4 drinks/mo 2198 8.39 23 4.33 664 15.40 46 11.56
Physical activity (Regular Walking) a No (Rarely) 5203 17.31 119 17.46 903 20.57 98 21.14
Yes (Regularly) 24 487 82.69 526 82.54 3549 79.43 350 78.86
Type of comorbidity a Atopic dermatitis 415 1.40 21 4.31 48 1.45 13 2.84
Lung cancer 25 0.07 1 0.16 22 0.43 1 0.13
Lung function b FVC (% pred) 92.01 (91.82–92.19) 89.18 (87.96–90.40) 90.29 (89.78–90.80) 84.12 (82.27–85.98)
FEV1 (% pred) 92.88 (92.70–93.06) 89.05 (87.87–90.24) 78.11 (77.60–78.62) 65.76 (63.64–67.88)
FEV1/FVC 0.80 (0.80–0.80) 0.78 (0.78–0.79) 0.64 (0.64–0.64) 0.58 ± (0.57–0.59)
GOLD Stage 1 26 011 87.50 498 78.64 2107 47.04 106 23.92
Stage 2 3655 12.43 145 20.89 2162 48.74 247 55.06
Stage 3 24 0.07 2 0.47 162 3.69 83 18.85
Stage 4 21 0.53 12 2.17
a

Categorical variables are presented as frequencies and percentages;

b

Continuous variables are presented means and 95% confidence intervals.

Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; FEV, forced expiratory volume.

Among the disease‐related factors, the lung function test results showed a decreasing mean FEV1/FVC value in the order of the NRD (0.80), asthma (0.78), COPD (0.64), and asthma +COPD (0.58) groups. With respect to the GOLD criteria, the NRD and asthma groups showed the highest prevalence in stage 1; the COPD group, in stages 1 and 2; and the asthma + COPD group, in stage 2.

Table S1 shows the logistic regression analysis results on the association between asthma and asthma + COPD, as well as the association between COPD and asthma + COPD. The results were adjusted for all demographic factors, health behavior, and disease‐related factors. The OR of having asthma + COPD among females with asthma, as compared with males with asthma, was 0.234 (95% CI 0.140–0.392), indicating a significantly negative association of asthma + COPD among females with asthma. With respect to age, the association between asthma and asthma + COPD increased with increasing age compared with those aged 40–49 years. In particular, the OR of having asthma + COPD among those aged ≥70 years was 6.479 (95% CI 3.327–12.615) in the asthma group, which showed the highest association. Regarding BMI, the OR of having asthma + COPD was high, with a value of 5.272 (95% CI 1.444–19.246) in underweight patients with asthma as compared with those with normal BMI, while the association was lower in overweight subjects (OR: 0.627; 95% CI 0.445–0.884). The OR of having asthma + COPD among females with COPD, as compared with males with COPD, was 2.235 (95% CI 1.397–3.577), indicating a significant association between asthma + COPD and females with COPD. In contrast to asthma, the association with asthma + COPD appeared higher among women with COPD than among men with COPD. With respect to age, the association between COPD and asthma + COPD decreased with increasing age as compared with those aged 40–49. Concerning BMI, the OR of having asthma + COPD in patients with COPD who were underweight was 1.804 (95% CI 1.024–3.177), whereas patients who were overweight were thought to have a higher risk of asthma + COPD (OR: 1.348, 95% CI 1.035–1.757).

Table 2 shows the results of the logistic regression analysis (adjusted for all demographic factors, health behavior, and disease‐related factors) on the associations among the asthma, COPD, and asthma + COPD groups.

TABLE 2.

Association of risk factors for asthma, COPD, and asthma + COPD among Korean participants in KNHANES 2008–2018

Asthma COPD Asthma + COPD
Category OR a 95% CI OR a 95% CI OR a 95% CI
Sex Men (ref.) 1.000 1.000 1.000
Women 2.550 1.764 3.687 0.294 0.255 0.338 0.652 0.411 1.033
Age (y) 40–49 (ref.) 1.000 1.000 1.000
50–59 0.972 0.713 1.325 2.592 2.205 3.046 1.566 0.983 2.495
60–69 1.117 0.796 1.568 6.676 5.678 7.848 3.720 2.304 6.008
≥70 1.274 0.878 1.849 12.327 10.383 14.634 6.399 3.824 10.709
Household income 1st quartile 1.191 0.867 1.638 1.222 1.062 1.405 1.568 1.040 2.366
2nd quartile 0.885 0.658 1.192 1.053 0.920 1.206 0.994 0.677 1.461
3rd quartile 1.078 0.798 1.455 1.019 0.889 1.167 1.008 0.685 1.483
4th quartile (ref.) 1.000 1.000 1.000
Education Elementary (<6 years) 1.482 1.043 2.106 1.478 1.267 1.723 1.533 0.971 2.419
Middle (7–9 years) 1.368 0.946 1.978 1.303 1.107 1.534 0.970 0.590 1.593
High (10–12 years) 0.836 0.614 1.139 1.166 1.012 1.343 0.842 0.552 1.282
College (>12 years) (ref.) 1.000 1.000 1.000
Occupation Unemployed (ref.) 1.000 1.000 1.000
Professions 0.872 0.348 2.186 0.803 0.599 1.077 0.350 0.078 1.559
Office work 1.305 0.881 1.933 0.898 0.725 1.112 0.702 0.377 1.305
Sales and services 0.897 0.555 1.452 0.956 0.776 1.180 0.651 0.296 1.430
Agriculture, forestry and fishery 0.753 0.487 1.163 1.170 0.928 1.475 0.977 0.560 1.702
Machine fitting and simple labor 0.929 0.687 1.255 1.060 0.938 1.198 0.684 0.472 0.991
Others 0.719 0.505 1.024 1.148 1.005 1.312 0.890 0.583 1.359
BMI (kg/m2) Normal weight (ref.) 1.000 1.000 1.000
Underweight 0.598 0.240 1.492 1.405 1.042 1.896 2.463 1.426 4.253
Overweight 1.255 1.038 1.518 0.693 0.633 0.759 0.870 0.681 1.112
Smoking status Nonsmoker (ref.) 1.000 1.000 1.000
Former 1.261 0.828 1.923 1.546 1.336 1.790 1.728 1.095 2.726
Current 1.272 0.883 1.830 2.336 2.029 2.689 2.145 1.320 3.484
Drinking status None (ref.) 1.000 1.000 1.000
≤1 drink/mo 0.779 0.615 0.987 0.885 0.786 0.996 0.721 0.525 0.990
2 drinks/mo to 3 drinks/mo 0.699 0.532 0.918 0.884 0.788 0.992 0.708 0.497 1.007
≥4 drinks/mo 0.578 0.339 0.987 0.919 0.795 1.064 0.793 0.507 1.242
Physical activity (regular walking) No (rarely) (ref.) 1.000 1.000 1.000
Yes (regularly) 1.085 0.840 1.402 0.958 0.859 1.069 0.991 0.742 1.324
Type of comorbidity Atopic dermatitis 3.175 1.792 5.624 1.059 0.714 1.569 2.093 1.050 4.171
Lung cancer 2.115 0.272 16.432 3.122 1.650 5.907 1.188 0.161 8.771
a

Odds ratios with adjustments using logistic regression models adjusted for sex, age, household income, education, occupation, BMI, smoking status, alcohol consumption, physical activity, and types of comorbidity.

Abbreviations: BMI, body mass index; CI, confidence interval; COPD, chronic obstructive pulmonary disease; KNHANES, Korean National Health and Nutrition Examination Survey; aOR, adjusted odds ratio.

Among the demographic factors, the female sex in the asthma group showed a higher association than the male sex, with an OR of 2.550 (95% CI 1.764–3.687), whereas for females in the COPD group, the association was significantly lower, with an OR of having asthma of 0.294 (95% CI 0.255–0.338). In the asthma group, there was no significant difference according to age. In the COPD group, the OR of having COPD increased with age: 50–59 years (2.592, 95% CI 2.205–3.046), 60–69 years (6.676, 95% CI 5.678–7.848), and ≥70 years (12.327, 95% CI 10.383–14.634), relative to the 40–49 years age bracket. In the asthma + COPD group, the OR of having asthma + COPD also increased with age: 60–69 years (3.720, 95% CI 2.304–6.008) and ≥70 years (6.399, 95% CI 3.824–10.709) relative to the 40–49 years age bracket. For household income, there were no associations among household incomes in the asthma group, whereas the low group (1.222, 95% CI 1.062–1.405) had a higher risk for COPD than the high group. Likewise, the low group (1.222, 95% CI 1.062–1.405) had a higher risk for asthma + COPD than the high group.

With respect to educational level, the association with asthma was higher among elementary school graduates (1.482, 95% CI 1.043–2.106) than among college graduates, whereas the association with COPD was higher among elementary school graduates (1.478, 95% CI 1.267–1.723), middle school graduates (1.303, 95% CI 1.107–1.534), and high school graduates (1.166, 95% CI 1.012–1.343) than among college graduates. In the asthma + COPD group, there was no statistically significant association. Based on occupation, machine fitting and simple labor (0.684, 95% CI 0.472–0.991) showed a lower association than being unemployed in the asthma + COPD group.

Among health behavior and disease‐related factors, overweight subjects (1.255, 95% CI 1.038–1.518) showed a higher association than those with normal weight in the asthma group, whereas underweight subjects (1.405, 95% CI 1.042–1.896) showed a high association with COPD, and overweight subjects (0.693, 95% CI 0.633–0.759) showed a low association with COPD. In the asthma + COPD group, underweight subjects (2.463, 95% CI 1.426–4.253) showed a high association with asthma + COPD. In the asthma group, there was no significant association with smoking status, whereas, in the COPD group, former smokers (1.546, 95% CI 1.336–1.790) and current smokers (2.336, 95% CI 2.029–2.689) showed a higher association than nonsmokers. A similar pattern was also found in the asthma + COPD group (former smokers: 1.728, 95% CI 1.095–2.726; current smokers: 2.145, 95% CI 1.320–3.484). With respect to alcohol consumption, individuals who consume any alcohol showed significantly lower associations with asthma and COPD than those who do not drink at all. In the asthma + COPD group, individuals who consume ≤1 drink per month showed a lower association. Individuals with a previous history of atopic dermatitis showed a higher association with asthma (3.175, 95% CI 1.792–5.624) and asthma + COPD (2.093, 95% CI 1.050–4.171), whereas individuals with a previous history of lung cancer showed a higher association with COPD (3.122, 95% CI 1.650–5.907).

4. DISCUSSION

The present study used reliable and nationally representative data to analyze the demographic characteristics, health behavior, disease‐related factors, and risk factors associated with respiratory diseases among 35 235 Korean adults aged ≥40 years.

In this study, women showed a high association with asthma than men. Such findings supported the results from a previous study reporting that 71% of adult asthma patients are women. 3 Although the exact role of sex hormones in the regulation of asthma has not been identified, it has been reported that ovarian hormones exacerbate and testosterone alleviates asthmatic airway inflammation. 18 Being overweight showed a higher association with asthma than being normal weight. This finding supports the results from a previous study reporting that obesity increased the risk of adulthood asthma by approximately 50% in both men and women. 19 People with a previous history of atopic dermatitis showed a significantly high association with asthma (3.175, 95% CI 1.792–5.624), which appears to be associated with atopic march, a phenomenon involving atopic dermatitis progressing to allergic asthma and allergic rhinitis. 20

Furthermore, women showed a lower association with COPD than men. Such findings support the fact that COPD is more frequent in men than women due to COPD being historically linked to smoking status and occupational exposure. 21 This association increases with age, as compared with those aged 40–49 years, and in particular, the OR of COPD in individuals aged ≥70 years was approximately 12 times higher. These findings support results from previous studies indicating that the risk of COPD increases with age. 5 , 12 Concerning income quartiles, the association with COPD was lower in high‐income groups than that in the low‐income group. With respect to BMI, underweight individuals showed a high association with COPD, whereas individuals who are overweight actually showed a lower risk. The findings were similar to those of a study in 2011 reporting that low BMI is associated with COPD. 5 Similar to previous studies, former and current smokers showed a higher association with COPD than nonsmokers. 22 In particular, individuals with a previous history of lung cancer showed a higher association with COPD, which had also been reported in previous studies. 23

Finally, individuals aged 60–69 and ≥70 years showed a higher association with asthma + COPD than those aged 40–49 years. These findings support the results from previous studies indicating that the prevalence of asthma + COPD increases significantly with age and that age is associated with asthma + COPD. 24 , 25 With respect to income quartiles and educational level, the risk factors of asthma + COPD showed largely similar characteristics as the risk factors of COPD, which supports previous studies reporting that many patients with COPD also have asthma + COPD and that patients with asthma + COPD share the same demographic characteristics and exhibit similar lung function test results as patients with COPD alone. 26 The results also revealed that underweight individuals had a high association with asthma + COPD, which was contradictory to previous studies reporting that high BMI is associated with asthma + COPD. 27 In the present study, the subjects were limited to adults aged ≥40 years. As a result, the association between asthma + COPD and COPD was even more pronounced. Consistent with COPD, former and current smokers showed a higher association with asthma + COPD than nonsmokers. Such findings could be considered similar to the results from previous studies showing no significant differences between the COPD and asthma + COPD groups in relation to smoking habits (former, current, and nonsmokers). 28 Lastly, individuals with a previous history of atopic dermatitis showed a high association with asthma + COPD. 26

Studies in the US have also used data from the KNHANES to investigate the status of respiratory diseases. The results revealed that the prevalence of asthma + COPD had increased from 0.96% to 1.05% between 2007 and 2012. The age‐standardized prevalence of asthma + COPD was higher among individuals with low socio‐economic status and previous history of myocardial infarction or stroke. Old age and smoking status showed even higher associations with the prevalence of asthma + COPD. Among the participants with COPD, a higher prevalence was correlated with being non‐Hispanic Black, being obese, and having a history of myocardial infarction or stroke. asthma + COPD is associated with the use of oxygen therapy for severe asthma and COPD. The participants with asthma + COPD showed a poorer FEV1 in the lung function test results than those with asthma or COPD alone. 29 With respect to risk factors, old age, smoking status, and obesity showed similar results as the present study. Participants with a low socio‐economic status are highly likely to present severe COPD together with frequent and uncontrolled asthma for a long time. 9

4.1. Strength and limitations

The present study had some limitations. First, because it was a cross‐sectional study using KNHANES data, caution should be taken when interpreting the causal relationships between the variables. In other words, whether the associated factors are independent causative factors or epiphenomenon factors cannot be known by their causal relationships. Second, asthma has a characteristic higher incidence at younger ages, but because the study population included only adults aged ≥40 years, the identification of factors may have been influenced by the fact that more COPD cases than asthma cases were included. Third, asthma was diagnosed by a doctor and thus may have been subject to underdiagnosis, overdiagnosis, or poor accessibility to health care services. 30 On other hand, we included patients diagnosed based on the pulmonary function test (laboratory diagnostic criteria) for COPD. The diagnosis of asthma is made based on a physician's subjective judgment, the diagnosis may not be as objective as COPD. There is the additional confounder that the physician's diagnosis of asthma would have been based on a number of different factors in that age group, such as gender and smoking history. Lastly, KNHANES was not created for the purpose of investigating chronic airway diseases. Therefore, the total participation rate was limited, and only participants with vital capacity measurements were included. Because lung function was not measured in all individuals who participated in KNHANES, selection bias cannot be discarded. To overcome such shortcomings, large‐scale prospective cohort studies are needed to identify the associations of suspected risk factors and actual causes with outcomes of respiratory diseases.

Despite these limitations, the present study also had the following strengths. First, it used data from surveys conducted by a Korean government agency. The surveys were nationwide and were conducted on sample populations from the same region using the same questions during the same survey period. Because the surveys targeted the general population, the obtained data have high reliability. Second, this was the first study to analyze the risk factors of three different respiratory diseases over multiple years. While previous studies have analyzed the risk factors of respiratory diseases, no study has analyzed such factors over multiple years. Additionally, the present study compared the associations of asthma‐asthma + COPD and COPD‐asthma + COPD to investigate which risk factors would increase the likelihood of asthma or COPD progressing to asthma + COPD. Finally, the present study measured the ORs of each respiratory disease relative to a group of healthy controls to identify the risk factors that influence specific respiratory diseases.

This study analyzed the correlation between respiratory diseases and associated factors from 2008–2018. As a result of the global COVID‐19 pandemic, there may have been changes to the status of respiratory diseases since 2019. Subsequent studies can comparatively analyze the status of respiratory diseases prior to and after the advent of the COVID‐19 pandemic by examining respiratory diseases after 2019. Therefore, this study provides useful data shedding light on the characteristics of respiratory diseases in the Korean population prior to the advent of COVID‐19. In the future, studies should analyze respiratory diseases and their associated factors in Korea also using data since 2019.

5. CONCLUSION

The present study identified the associations between respiratory diseases and demographic factors, health behavior, and disease‐related factors. In particular, the independent risk factors influencing specific diseases were being a woman and having a previous history of atopic dermatitis for asthma; older age, being a current smoker, and having a previous history of lung cancer for COPD; and older age, being underweight, being a current smoker, and having a previous history of atopic dermatitis for asthma + COPD. Our findings could be used to developing policies to treatment of COVID‐19, respiratory diseases and the prevention of infectious diseases.

CONFLICT OF INTEREST

The authors have no conflict of interests to declare.

ETHICS STATEMENT

The KNHANES IV–VII were conducted by the Korea Centers for Disease Control and Prevention (KCDC) and written consent was obtained from all participants. All survey protocols were approved by the Institutional Review Board (IRB) of the KCDC (approval numbers: 2008‐04EXP‐01‐C, 2009‐01CON‐03‐2C, 2010‐02CON‐21‐C, 2011‐02CON‐06‐C, 2012‐01EXP‐01‐2C, 2013‐07CON‐03‐4C, 2013‐12EXP‐03‐5C, and 2018‐01‐03‐P‐A). The data from KNHANES is available on the ‘Korea National Health and Nutrition Examination Survey’ website (http://knhanes.cdc.go.kr). The present study was conducted after approval from the IRB (JASENG IRB File No. 2021‐05‐013).

AUTHOR CONTRIBUTIONS

Conceptualization: Yoon Jae Won, Sook‐Hyun Lee, In‐Hyuk Ha. Data curation: Yoon Jae Won, Yu‐cheol Lim, In‐Hyuk Ha. Formal analysis: Yu‐cheol Lim, In‐Hyuk Ha. Methodology: Yoon Jae Won, Sook‐Hyun Lee, In‐Hyuk Ha. Project administration: Sook‐Hyun Lee, Beom‐Joon Lee, In‐Hyuk Ha. Validation: Yoon Jae Lee, Maurits Van den Noort, Beom‐Joon Lee. Writing – original draft: Yoon Jae Won, Sook‐Hyun Lee, In‐Hyuk Ha. Writing – review & editing: Yoon Jae Won, Sook‐Hyun Lee, Yu‐cheol Lim, Yoon Jae Lee, Maurits van den Noort, Beom‐Joon Lee, In‐Hyuk Ha.

Supporting information

Table S1. Association of risk factors for asthma+COPD among Korean participants with asthma or COPD in the KNHANES 2008–2018

ACKNOWLEDGEMENT

Not applicable.

Won YJ, Lee S‐H, Lim Y‐C, et al. Characteristics and difference of respiratory diseases in Korean adults aged ≥40 years: A cross‐sectional study. Clin Respir J. 2023;17(1):29‐39. doi: 10.1111/crj.13558

Funding Information This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI20C1205).

Contributor Information

Beom‐Joon Lee, Email: franchisjun@naver.com.

In‐Hyuk Ha, Email: hanihata@gmail.com.

DATA AVAILABILITY STATEMENT

The datasets generated and analyzed during the current study are available in the KNHANES repository (http://knhanes.cdc.go.kr). All data from KNHANES‐VI are coded and freely available.

REFERENCES

  • 1. Ferkol T, Schraufnagel D. The global burden of respiratory disease. Ann am Thorac Soc. 2014;11(3):404‐406. doi: 10.1513/AnnalsATS.201311-405PS [DOI] [PubMed] [Google Scholar]
  • 2. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224‐2260. doi: 10.1016/s0140-6736(12)61766-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Toskala E, Kennedy DW. Asthma risk factors. Int Forum Allergy Rhinol. 2015;5 Suppl 1(Suppl 1):S11‐S16. doi: 10.1002/alr.21557 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Park SY, Kim JH, Kim HJ, et al. High prevalence of asthma in elderly women: findings from a Korean national health database and adult asthma cohort. Allergy Asthma Immunol Res. 2018;10(4):387‐396. doi: 10.4168/aair.2018.10.4.387 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Hong JY, Jung JY, Lee MG, et al. Changes in the prevalence of COPD in Korea between 2001 and 2011 in the KNHANES data. Respir Med. 2017;125:12‐18. doi: 10.1016/j.rmed.2017.02.019 [DOI] [PubMed] [Google Scholar]
  • 6. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non‐smokers. Lancet (London, England). 2009;374(9691):733‐743. doi: 10.1016/s0140-6736(09)61303-9 [DOI] [PubMed] [Google Scholar]
  • 7. Postma DS, Rabe KF. The asthma‐COPD overlap syndrome. N Engl J Med. 2015;373(13):1241‐1249. doi: 10.1056/NEJMra1411863 [DOI] [PubMed] [Google Scholar]
  • 8. Mekov E, Nuñez A, Sin DD, et al. Update on asthma‐COPD overlap (ACO): a narrative review. Int J Chron Obstruct Pulmon Dis. 2021;16:1783‐1799. doi: 10.2147/copd.S312560 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Kim J, Kim YS, Kim K, et al. Socioeconomic impact of asthma, chronic obstructive pulmonary disease and asthma‐COPD overlap syndrome. J Thorac Dis. 2017;9(6):1547‐1556. doi: 10.21037/jtd.2017.05.07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Park J, Kim EK, Kim MA, et al. Increased risk of exacerbation in asthma predominant asthma‐chronic obstructive pulmonary disease overlap syndrome. Tuberc Respir Dis. 2018;81(4):289‐298. doi: 10.4046/trd.2017.0064 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Kim MH, Rhee CK, Kim K, et al. Heterogeneity of asthma and COPD overlap. Int J Chron Obstruct Pulmon Dis. 2018;13:1251‐1260. doi: 10.2147/copd.S152916 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Lee SH, Hwang ED, Lim JE, et al. The risk factors and characteristics of COPD among nonsmokers in Korea: an analysis of KNHANES IV and V. Lung. 2016;194(3):353‐361. doi: 10.1007/s00408-016-9871-6 [DOI] [PubMed] [Google Scholar]
  • 13. Gasmi A, Peana M, Pivina L, et al. Interrelations between COVID‐19 and other disorders. Clin Immunol (Orlando, Fla). 2021;224:108651. doi: 10.1016/j.clim.2020.108651 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347‐365. doi: 10.1164/rccm.201204-0596PP [DOI] [PubMed] [Google Scholar]
  • 15. Hong KS, Kim MC, Ahn JH. Sarcopenia is an independent risk factor for NAFLD in COPD: a nationwide survey (KNHANES 2008–2011). Int J Chron Obstruct Pulmon Dis. 2020;15:1005‐1014. doi: 10.2147/COPD.S249534 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Jo YS, Choi SM, Lee J, et al. The relationship between chronic obstructive pulmonary disease and comorbidities: a cross‐sectional study using data from KNHANES 2010–2012. Respir Med. 2015;109(1):96‐104. doi: 10.1016/j.rmed.2014.10.015 [DOI] [PubMed] [Google Scholar]
  • 17. Kim MA, Noh CS, Chang YJ, et al. Asthma and COPD overlap syndrome is associated with increased risk of hospitalisation. Int J Tuberc Lung Dis. 2015;19(7):864‐869. doi: 10.5588/ijtld.14.0327 [DOI] [PubMed] [Google Scholar]
  • 18. Fuseini H, Newcomb DC. Mechanisms driving gender differences in asthma. Curr Allergy Asthma Rep. 2017;17(3):19. doi: 10.1007/s11882-017-0686-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Rönmark E, Andersson C, Nyström L, Forsberg B, Järvholm B, Lundbäck B. Obesity increases the risk of incident asthma among adults. Eur Respir J. 2005;25(2):282‐288. doi: 10.1183/09031936.05.00054304 [DOI] [PubMed] [Google Scholar]
  • 20. Aw M, Penn J, Gauvreau GM, Lima H, Sehmi R. Atopic March: collegium internationale allergologicum update 2020. Int Arch Allergy Immunol. 2020;181(1):1‐10. doi: 10.1159/000502958 [DOI] [PubMed] [Google Scholar]
  • 21. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765‐773. doi: 10.1016/s0140-6736(07)61380-4 [DOI] [PubMed] [Google Scholar]
  • 22. Backman H, Eriksson B, Rönmark E, et al. Decreased prevalence of moderate to severe COPD over 15 years in northern Sweden. Respir Med. 2016;114:103‐110. doi: 10.1016/j.rmed.2016.03.013 [DOI] [PubMed] [Google Scholar]
  • 23. Powell HA, Iyen‐Omofoman B, Baldwin DR, Hubbard RB, Tata LJ. Chronic obstructive pulmonary disease and risk of lung cancer: the importance of smoking and timing of diagnosis. J Thorac Oncol. 2013;8(1):6‐11. doi: 10.1097/JTO.0b013e318274a7dc [DOI] [PubMed] [Google Scholar]
  • 24. de Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle‐aged and elderly people from the general population. PLoS ONE. 2013;8(5):e62985. doi: 10.1371/journal.pone.0062985 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Fu JJ, McDonald VM, Gibson PG, Simpson JL. Systemic inflammation in older adults with asthma‐COPD overlap syndrome. Allergy Asthma Immunol Res. 2014;6(4):316‐324. doi: 10.4168/aair.2014.6.4.316 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Alshabanat A, Zafari Z, Albanyan O, Dairi M, FitzGerald JM. Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis. PLoS ONE. 2015;10(9):e0136065. doi: 10.1371/journal.pone.0136065 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Menezes AMB, Montes de Oca M, Pérez‐Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD‐asthma. Chest. 2014;145(2):297‐304. doi: 10.1378/chest.13-0622 [DOI] [PubMed] [Google Scholar]
  • 28. Miravitlles M, Soriano JB, Ancochea J, et al. Characterisation of the overlap COPD‐asthma phenotype. Focus on physical activity and health status. Respir Med. 2013;107(7):1053‐1060. doi: 10.1016/j.rmed.2013.03.007 [DOI] [PubMed] [Google Scholar]
  • 29. Mendy A, Forno E, Niyonsenga T, Carnahan R, Gasana J. Prevalence and features of asthma‐COPD overlap in the United States 2007–2012. Clin Respir J. 2018;12(8):2369‐2377. doi: 10.1111/crj.12917 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Nascimento OA, Camelier A, Rosa FW, Menezes AM, Pérez‐Padilla R, Jardim JR. Chronic obstructive pulmonary disease is underdiagnosed and undertreated in São Paulo (Brazil): results of the PLATINO study. Braz J Med Biol Res. 2007;40(7):887‐895. doi: 10.1590/s0100-879x2006005000133 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Table S1. Association of risk factors for asthma+COPD among Korean participants with asthma or COPD in the KNHANES 2008–2018

Data Availability Statement

The datasets generated and analyzed during the current study are available in the KNHANES repository (http://knhanes.cdc.go.kr). All data from KNHANES‐VI are coded and freely available.


Articles from The Clinical Respiratory Journal are provided here courtesy of Wiley

RESOURCES